DURHAM, N.C., Aug. 31, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) today announced that results from an 8-week cosmetic study showed that the topical application of DERMACYTE® Oxygen Concentrate, an oxygen-rich skin care lotion, appears to improve the appearance of fine lines and the perception of skin appearance. The study was conducted by Steven H. Dayan, MD, of DeNova Research in Chicago with funding provided by Oxygen Biotherapeutics.
